FDA.reportPublic FDA data

tolvaptan 45 MG Oral Tablet [Jynarque]

RxCUI
2044361
RxNorm name
tolvaptan 45 MG Oral Tablet [Jynarque]
Display name
tolvaptan 45 MG Oral Tablet [Jynarque]
Full name
tolvaptan 45 MG Oral Tablet [Jynarque]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:55

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3febc0a1-9e5a-4ce0-843d-210f21d862c4JYNARQUE 45 MG Oral Tablet [PSN] · tolvaptan 45 MG Oral Tablet [Jynarque] [SBD] · Jynarque 45 MG Oral Tablet [SY]319These highlights do not include all the information needed to use JYNARQUE safely and effectively. See full prescribing information for JYNARQUE. JYNARQUE ® (tolvaptan) tablets, for oral use Initial U.S. Approval: 200920251106